Medoclor

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Medoclor

Quick Facts

Property Description
Active ingredient Cefaclor
Form Capsule, oral suspension, extended-release tablet
Pharmacological class Antibiotic (Second-Generation Cephalosporin)
Common purpose Combating bacterial infections
Origin Semisynthetic

What Type of Medicine is Medoclor (Cefaclor)?

Medoclor is a prescription medication whose active ingredient is Cefaclor, classified as an antibiotic that belongs to the beta -Lactam cephalosporin family of anti-infective agents. The active ingredient is a semisynthetic derivative, chemically engineered to optimize its action against pathogens. Cefaclor is specifically categorized as a second-generation cephalosporin, positioning it within a group of drugs recognized for their broad-spectrum capability against a wide range of common bacterial strains. Consequently, this medicine is utilized to eliminate infections caused by susceptible bacteria.


Composition, Origin, and Available Forms

The medication is a single-active ingredient product formulated exclusively for oral administration (by mouth). Cefaclor is available in three primary delivery forms: a standard capsule, an oral suspension (a liquid form, which is often a key feature for pediatric patients), and an extended-release tablet. The availability of these distinct forms allows healthcare professionals to choose the most appropriate method for patient intake.


What is the General Purpose of Medoclor's Bactericidal Action?

The overall purpose of Medoclor is to combat and eliminate infections caused by susceptible bacteria throughout the body, such as those that lead to a typical ear infection or skin structure infection. Cefaclor's core function is bactericidal, meaning it actively kills the infectious organisms rather than simply halting their growth (a bacteriostatic effect). It achieves this by disrupting the bacteria's ability to construct a stable outer shell, or cell wall, which is essential for survival. This targeted bactericidal action is fundamental to its role as an anti-infective agent.

What side effects are possible with Medoclor?

Possible Side Effects and Safety Information

Medoclor (Cefaclor) is associated with an official safety profile that classifies potential adverse reactions based on their expected frequency and the body system affected, according to government regulatory standards. The medicine's risk characteristics are defined by these officially documented effects, which fall into categories such as Gastrointestinal disorders and Immune system disorders.

Adverse Reaction Classifications

Adverse effects are formally categorized by their incidence rate in regulatory documents:

Frequency Classification Examples of Documented Effects
Common (1/100 to 1/10) Diarrhea, nausea, rash.
Uncommon (1/1,000 to 1/100) Vomiting, eosinophilia, pruritus, urticaria.
Rare to Very Rare (< 1/1,000) Serum sickness-like reaction, anaphylaxis, severe cutaneous reactions (SJS, TEN).

Serious and Clinically Significant Reactions

The label explicitly highlights certain severe or clinically significant adverse reactions. These include life-threatening hypersensitivity reactions (e.g., anaphylaxis, angioedema) and severe gastrointestinal complications like pseudomembranous colitis. Other serious effects involve the blood and lymphatic system (e.g., aplastic anemia) and renal disorders (e.g., interstitial nephritis).

Population and Safety Constraints

The safety documentation notes specific constraints, including the risk of cross-sensitivity in individuals with a known allergy to penicillin. Dose adjustments are generally noted as required for patients with renal impairment. Furthermore, the regulatory safety text notes the potential for the medicine to enhance the effect of oral anticoagulants and the increased risk of nephrotoxicity when used concurrently with certain other medicines.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Cefaclor (Medoclor) requires immediate medical attention. Official regulatory documents describe the presentation of an acute overdose primarily with gastrointestinal symptoms, including nausea, vomiting, epigastric distress, and diarrhea.


Documented Manifestations and Severe Outcomes

Official labeling notes that in cases of larger overdoses, there is a potential for severe systemic complications. These include effects on the renal and neurological systems, such as the potential for seizures and, rarely, acute renal failure. Individuals with pre-existing renal impairment may face an increased risk of these severe outcomes. Laboratory findings may show abnormalities, including hematuria, proteinuria, and elevations in BUN and creatinine.


Emergency Actions and Management

Due to the risk of toxic sequelae, regulatory authorities mandate that patients seek medical attention immediately and contact a poison control center. Treatment is defined as strictly symptomatic and supportive, as no specific antidote is known. Management procedures may include measures to secure the airway, oxygenation, and ventilation, with gastric lavage and activated charcoal potentially being useful. Hospital monitoring is required for assessment, specifically to check electrolyte status and renal function.

Therapeutic Uses of Medoclor

What Medoclor Treats: Main Uses and Benefits

Medoclor (Cefaclor) is commonly used to help with a range of acute bacterial infections. It provides support that helps ease the overall symptom burden during periods of acute distress. The medication is applied across domains where additional symptomatic support is needed, including the skin, ears, throat, lower respiratory, and urinary tracts.


Key Therapeutic Domains and Symptom Relief

This medication is relevant in clinical settings that involve acute or unstable symptom patterns from various infections. It is used to address symptom clusters that may become intense or disruptive, such as those related to physical discomfort, systemic imbalance, and inflammatory states.

Medoclor is commonly used across conditions presenting with acute episodes, including Respiratory Infections (like bronchitis and tonsillitis), Otolaryngological Infections (such as otitis media and sinusitis), Urinary Tract Infections (such as cystitis), and Skin Structure Infections. This supports general well-being during symptomatic phases when symptoms interfere with routine activities.


Quick Fact: Focus on Acute Symptom Management

Quick Fact: Focus on Target Symptom Category Therapeutic Benefit
Acute Symptom Management Symptoms related to physical discomfort and inflammatory states Contributes to easing the overall symptom load during difficult episodes.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Medoclor?

Absolute Contraindications

Medoclor is strictly contraindicated and must not be used by patients who have a documented hypersensitivity or allergy to the active ingredient, Cefaclor, or to any other antibiotic in the cephalosporin class. Use is also prohibited in individuals with a history of a major, immediate-type allergic reaction to penicillin.

Age and Population Restrictions

  • Infants: The safety and effectiveness of Medoclor are not established for infants under one month of age.
  • Children and Adolescents: The capsule and oral suspension forms are approved for use in patients one month of age and older. However, the extended-release tablet is restricted to individuals 16 years of age and older.
  • Older Adults: Use is permitted, but caution is advised due to the potential for age-related decreases in kidney function.

Conditional Use and Status

  • Kidney Function: Use with caution is mandated in the presence of markedly impaired renal function.
  • Gastrointestinal History: Patients with a history of gastrointestinal disease, particularly colitis, require careful use.
  • Pregnancy Status: Use is restricted to situations where it is deemed clearly needed, as safety has not been established.
  • Lactation: Caution is required, as small amounts of the drug are detectable in breast milk and the potential effect on the nursing infant is not known.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Medoclor (Cefaclor) documents specific patterns of interaction with other medicines and products, primarily involving renal clearance, gastrointestinal absorption, and pharmacodynamic effects.

Interacting Substance Official Regulatory Outcome
Probenecid Increases Cefaclor plasma concentrations due to regulatory-documented inhibition of renal excretion.
Oral Anticoagulants (e.g., Warfarin) Co-administration may result in an enhanced anticoagulant effect, which necessitates close monitoring of prothrombin time.
Aluminum/Magnesium Antacids Diminish the extent of Cefaclor absorption. The extended-release form requires separation of at least one hour from antacid administration.
Food Reduces the peak plasma concentration ( C max) of Cefaclor, although the total amount absorbed remains unchanged.
Aminoglycosides/Furosemide Co-administration is associated with a documented increased risk of nephrotoxicity.
Oral Hormonal Contraceptives May experience a decrease in effectiveness via altered intestinal flora.

These statements define the regulatory constraints for co-administration. The interaction profile is structured around managing alterations in systemic exposure and pharmacodynamic outcomes. Individuals with markedly impaired renal function exhibit reduced Cefaclor clearance, which results in a prolonged elimination half-life. The documented restrictions are established to manage these documented effects as described in government prescribing information.

Mechanism of Action

How Medoclor Works

Medoclor's mechanism of action involves disrupting the processes required for bacterial structural integrity, resulting in the failure of the bacterial cell.


Blocking Bacterial Cell Wall Construction

Medoclor works by forming a permanent, irreversible bond with essential bacterial enzymes called Penicillin-Binding Proteins (PBPs), which are necessary for the final stages of cell wall synthesis. The drug acts as a covalent inhibitor, preventing the cross-linking of peptidoglycan chains, which are essential for assembling the rigid, structural layer of the bacterial cell wall.


Initiating Structural Collapse and Bacteriolysis

This molecular blockade initiates a cascade leading to cell wall failure. The formation of a structurally defective cell wall leaves the bacteria vulnerable to high internal osmotic pressure. This effect, often coupled with the activation of the bacteria's own self-degrading enzymes, causes the cell wall to rupture, leading to bacteriolysis (bacterial cell death). The systemic consequence is the reduction in the population of susceptible bacteria. The mechanism can be constrained by bacterial defenses, such as the production of beta-lactamase enzymes that chemically inactivate the drug.

Dosage and Administration Information

How Medoclor (Cefaclor) is Used

Medoclor (Cefaclor) is administered exclusively through the oral route, utilizing three primary official formulations: a standard capsule, an oral suspension, and an extended-release (ER) tablet. The specific formulation dictates the dosing schedule and administration requirements.

Official Dosing and Frequency Patterns

The immediate-release (IR) forms, which include the capsule and the liquid suspension, are typically dosed every 8 hours (three times daily). The standard adult dose begins at 250 mg, though higher doses up to 500 mg may be used for more severe infection scenarios, with the established maximum daily intake not to exceed 4 grams. Conversely, the extended-release tablet (available in 375 mg or 500 mg) is administered every 12 hours (twice daily).

Procedural Administration Constraints

The IR capsule and suspension forms may be administered with or without food. However, the ER tablet must be taken with food to ensure adequate absorption and must be swallowed whole—it is a critical procedural requirement that the tablet is not cut, crushed, or chewed. The oral suspension requires reconstitution with water before use. For pediatric patients, the administration is based on a weight-based calculation, such as 20 mg/kg/day in divided doses.

Treatment Duration

Treatment courses generally last 7 to 10 days. For infections specifically caused by Streptococcus pyogenes, the official protocol mandates that administration must be maintained for a minimum of 10 days.

Recent Clinical Evidence

Clinical Research for Approved Indications

Research examining Medoclor's role in acute infections across the body, including the ear, nose, throat, lower respiratory tract, urinary tract, and skin, was constructed primarily through Randomized Controlled Trials (RCTs) and Controlled Comparative Studies. These trials were conducted during periods of increased symptom activity and monitored two primary outcomes: the Clinical Cure Rate (how symptoms evolved in the observed populations) and the Bacteriological Eradication Rate (whether the target organism was no longer detectable).

Studies reported patterns observed when the medicine was evaluated against a placebo and against other agents used in similar conditions. The findings describe group patterns related to Clinical Cure and Bacteriological Eradication over defined short-term intervals, typically within the first two weeks post-treatment. This research contributed to the broader evidence landscape for acute infection management.


Evidence Gaps and Special Populations

Research explored the medicine's use in specific groups, including Pediatric Patients concerning common childhood infections, such as otitis media. Furthermore, research examined how the medicine is processed in Adults who presented with underlying renal (kidney) impairment.

However, the evidence is specific to infections caused by organisms identified as susceptible and is limited because the follow-up durations were short across most studies. As a result, long-term effects are not fully established regarding durability or recurrence prevention. Research provides limited insight into its activity against certain resistant bacterial strains and lacks extensive modern comparative evidence against newer antibiotic classes.

Key Studies & References MedlinePlus: Cefaclor (For general purpose/uses and patient context)

Frequently Asked Questions (FAQ)

Common questions about Medoclor (FAQ)


Q: What should I do if I miss taking Medoclor?

Official patient guidance suggests taking the missed dose as soon as it is remembered. However, if it is almost time for your next scheduled dose, official guidance suggests the missed dose be skipped. This approach helps to avoid taking a double dose.


Q: How long does Medoclor typically take to start working?

According to patient information, individuals typically begin to feel an improvement or see initial signs of relief during the first few days of the treatment course. As with any medicine, the timeline for noticing effects can vary among individuals.


Q: What happens if I stop taking Medoclor suddenly?

Regulatory guidance emphasizes the importance of completing the full prescribed course of treatment. Stopping the course too soon is associated with the potential for the infection not being fully resolved or for the bacteria to develop resistance.


Q: Is there a maximum time someone can stay on Medoclor?

Official documents note that daily doses up to 4 grams have been administered safely to subjects for periods up to 28 days.


Q: Can Medoclor be used during pregnancy or while breastfeeding?

Official documents state that the use of the medicine during pregnancy is restricted to situations where it is considered clearly needed. During lactation (breastfeeding), trace amounts of the drug are detectable in breast milk, and official caution is required.


Q: Does Medoclor have an impact on fertility?

Studies conducted in animals, at doses higher than the maximum human dose, have not revealed evidence of impaired fertility. Official regulatory documents do not indicate that the medicine affects the ability to reproduce.


Q: Can Medoclor cause changes in mood or behavior?

The official drug labeling lists central nervous system and psychiatric effects of an uncertain causal relationship. These include rare reports of reversible effects such as hyperactivity, agitation, nervousness, insomnia, confusion, and hallucinations.


Q: Is it normal to feel tired or dizzy after starting Medoclor?

The official labeling for the medicine reports dizziness and somnolence (drowsiness or tired feeling) as adverse effects. These effects are reported rarely and are listed as central nervous system issues with an uncertain causal relationship to the medicine.


Q: Does Medoclor work right away, or does it take time to build up in the body?

The medicine is well absorbed after being taken by mouth. Pharmacological studies show that peak concentrations in the plasma (the highest level of the drug in the bloodstream) are typically achieved quickly, in about 0.5 to 1 hour.


Q: Is Medoclor still effective if it's taken after food?

Regulatory information indicates that Medoclor is still effective when taken with food. While the presence of food in the stomach may cause a delay in the initial absorption, the total amount of the drug absorbed into the body remains unchanged.


Q: What kind of studies have been done on Medoclor's use in children?

Studies have examined the use of the oral suspension and capsule forms in pediatric patients, specifically for children one month of age and older. This research focused on common childhood infections, such as otitis media (ear infection).


Q: Has Medoclor been withdrawn from any market for safety reasons?

The FDA determined that the extended-release form of this medicine was not withdrawn from sale for reasons related to safety or effectiveness. One minor indication was removed from the label because the FDA determined it was not an appropriate use for an antibacterial drug.


Q: What if Medoclor doesn't seem to be working for me?

Patient information suggests that individuals contact a healthcare professional if symptoms do not improve or if they worsen during the treatment course. This allows a professional to evaluate the treatment plan.


Q: Why do doctors prescribe Medoclor for different conditions?

The medicine is officially indicated for the treatment of various infections across the body, including those in the respiratory tract, ear, skin, and urinary tract. This is due to its proven action against a spectrum of specific, susceptible bacterial strains.


Q: Can taking Medoclor cause long-term problems?

Official regulatory text notes that prolonged use of anti-infective agents like this may result in the overgrowth of non-susceptible organisms, sometimes called a superinfection. Other serious adverse effects are generally classified as rare or transient.


Q: Is Medoclor safe for older adults (geriatric patients)?

Use in older adults is generally permitted, following the same guidance as for other adults. However, official caution is specifically advised for this population, particularly for individuals with age-related decreases in kidney function.


Q: Does Medoclor interact with alcohol consumption?

The official interaction profile provided in regulatory documents does not list a specific interaction between the medicine and alcohol. Despite this, patient materials note that alcohol consumption is a topic for discussion with a healthcare professional.


Q: Can Medoclor be taken at the same time as vitamin supplements?

The official list of documented drug interactions does not include vitamin supplements. General patient information suggests that individuals inform a healthcare provider about all vitamins and supplements being taken when starting the medicine.


Q: How often do people usually need to take Medoclor?

The different formulations of the medicine are typically prescribed to be taken either every 8 hours (three times daily) or every 12 hours (twice daily), depending on the specific product and treatment plan.


Q: Does Medoclor have any specific dietary restrictions?

Regulatory-based patient information generally suggests continuing a normal diet while taking this medicine, unless an individual is specifically instructed otherwise by a healthcare provider. There are no widely documented, mandatory dietary restrictions.

How should Medoclor be stored and disposed of?

How to Store and Dispose of Medoclor (Cefaclor)

The official storage conditions for Medoclor, which contains Cefaclor, differ based on its form.


Storage Requirements

Formulation Required Conditions
Capsules/Tablets Store at controlled room temperature, 15 C to 30 C (59 F to 86 F), protected from light and moisture.
Oral Suspension (Reconstituted) Requires storage in a refrigerator (2 C to 8 C). It must not be frozen and is stable for only 14 days.

All forms must be kept in a tightly closed, original container and stored out of the sight and reach of children. Unused or expired Medoclor must not be thrown away via wastewater or household trash. Disposal requires returning the medicine to a pharmacist or using an approved waste disposal collection program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Medoclor found in:

A-Z Index: